Lannett had cautioned that a major restructuring was likely as its operations and balance sheet faltered under a massive debt pile – now that has become a reality, under a proposed plan that will hand the company keys to lenders.
Foundering manufacturer Lannett expects soon to file for Chapter 11 bankruptcy protection in the US, after announcing a prepackaged restructuring support agreement with its variety of creditors intended to erase more than half-a-billion dollars from the company’s total debt pile.
Following completion of the proposed transaction, the Philadelphia-based firm’s secured lenders will own Lannett’s equity and the company’s existing stock...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
